An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
NCT ID: NCT01615068
Last Updated: 2018-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1007 participants
OBSERVATIONAL
2012-06-05
2017-11-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu
NCT00153218
A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
NCT00097487
A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease
NCT00191373
Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
NCT00051103
Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)
NCT00095706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Initial diagnosis of HER2+ MBC, as diagnosed by the treating physician, no more than 6 months prior to study enrollment
* Availability of cancer-specific historical data points in the patient's medical records
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Genentech, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Genentech, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Vincent'S Hospital; Birmingham Hematology Oncology Associates, Llc
Birmingham, Alabama, United States
University of South Alabama; Mitchell Cancer Institute
Mobile, Alabama, United States
Arizona Oncology Associates, PC - NAHOA
Sedona, Arizona, United States
Arizona Oncology
Tucson, Arizona, United States
Genesis Cancer Center
Hot Springs, Arkansas, United States
NEA Baptist Clinic
Jonesboro, Arkansas, United States
Hematology Oncology Services of Arkansas
Little Rock, Arkansas, United States
Highlands Oncology Group
Rogers, Arkansas, United States
East Valley Hem/Onc Med Group; Metropolitan Hem Onc.
Burbank, California, United States
South Bay Oncology Hematology Partners
Campbell, California, United States
California Cancer Associates for Research & Excellence, Inc.
Encinitas, California, United States
ROBERT A. MOSS, M.D., F.A.C.P., Inc
Fountain Valley, California, United States
California Oncology of the Central Valley
Fresno, California, United States
Cancer Care Associates
Fresno, California, United States
St. Jude Heritage Healthcare; Virgiia K.Crosson Can Ctr
Fullerton, California, United States
University of Southern California
Los Angeles, California, United States
UCLA School of Medicine
Los Angeles, California, United States
Comprehensive Cancer Care
Palm Springs, California, United States
Univ of Calif, San Francisco; Breast Cancer Center
San Francisco, California, United States
Coastal Integrative Cancer Care
San Luis Obispo, California, United States
Central Coast Medical Oncology
Santa Maria, California, United States
Sutter Pacific Medical Foundation
Santa Rosa, California, United States
Kaiser Permanente Of Colorado
Denver, Colorado, United States
Rocky Mountain Cancer Center - Denver
Denver, Colorado, United States
Mile High Oncology
Littleton, Colorado, United States
Connecticut Oncology Group
Middletown, Connecticut, United States
Yale Cancer Center
New Haven, Connecticut, United States
Hematology Oncology P.C.
Stamford, Connecticut, United States
MedStar Washington Hosp Center
Washington D.C., District of Columbia, United States
Lynn Cancer Institute - West
Boca Raton, Florida, United States
University of Miami; Dept Sylvester Cancer Center
Deerfield Beach, Florida, United States
Florida Cancer Specialists - Fort Myers (New Hampshire Ct)
Fort Myers, Florida, United States
Memorial Cancer Institute
Hollywood, Florida, United States
Baptist - MD Anderson Cancer Center
Jacksonville, Florida, United States
Florida Oncology Associates
Jacksonville, Florida, United States
Lakeland Regional Cancer Center
Lakeland, Florida, United States
Md Anderson Cancer Center Orlando
Orlando, Florida, United States
Florida Cancer Research Institute
Plantation, Florida, United States
Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building)
St. Petersburg, Florida, United States
Space Coast Medical Associates
Titusville, Florida, United States
Peachtree Hematology & Oncology Consultants, Pc
Atlanta, Georgia, United States
Northwest Georgia Oncology Centers PC - Marietta
Marietta, Georgia, United States
Summit Cancer Care PC
Savannah, Georgia, United States
Kootenai Cancer Center
Post Falls, Idaho, United States
Alton Memorial Hospital; Outpatient Clinic and Infusion Center
Alton, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Mid-Illinois Hematology
Normal, Illinois, United States
Oncology Specialists, S.C.
Park Ridge, Illinois, United States
Orchard Healthcare Research Inc.
Skokie, Illinois, United States
Carle Cancer Center
Urbana, Illinois, United States
Oncology Hematology Assoc
Evansville, Indiana, United States
McFarland Clinic
Ames, Iowa, United States
University of Iowa
Iowa City, Iowa, United States
Mercy Medical Ctr-North Iowa ; Mercy Cancer Center
Mason City, Iowa, United States
Cancer Center of Kansas
Wichita, Kansas, United States
James Graham Brown Cancer Center, University of Louisville
Louisville, Kentucky, United States
Baptist Hospital East
Louisville, Kentucky, United States
Mary Bird Perkins Cancer Ctr
Baton Rouge, Louisiana, United States
Medical Oncology LLC
Baton Rouge, Louisiana, United States
Lafayette General Medical Center
Lafayette, Louisiana, United States
Mercy Oncology / Hematology Center; Oncology
Portland, Maine, United States
Western Maryland Health Sys
Cumberland, Maryland, United States
Associates in Oncology/Hematology P.C.
Rockville, Maryland, United States
Capitol Hematology & Oncology
Silver Spring, Maryland, United States
St. Joseph Medical Center
Towson, Maryland, United States
Carroll County Cancer Center
Westminster, Maryland, United States
Berkshire Hematology, Oncology Pc
Pittsfield, Massachusetts, United States
Cancer & Hematology Centers of Western Michigan
Grand Rapids, Michigan, United States
West Michigan Cancer Center
Kalamazoo, Michigan, United States
Southdale Cancer Clinic U of M Medical Center, Fairview- Edina
Edina, Minnesota, United States
Minnesota Oncology Hematology, Pa
Minneapolis, Minnesota, United States
Park Nicollet Clinic Cancer Center
Saint Louis Park, Minnesota, United States
Jackson Oncology Associates, PLLC
Jackson, Mississippi, United States
Jefferson City Medical Group
Jefferson City, Missouri, United States
Research Medical Center; Pharmacy
Kansas City, Missouri, United States
Christian Hospital; Outpatient Cancer and Infusion Center
St Louis, Missouri, United States
St. John'S Mercy Medical Center; David C. Pratt Cancer Center
St Louis, Missouri, United States
Billings Clinic Research Center
Billings, Montana, United States
Montana Cancer Specialists
Missoula, Montana, United States
Southeast Nebraska Cancer Center;; Southeast Nebraska Hematology and Oncology
Lincoln, Nebraska, United States
Cancer Alliance of Nebraska
Omaha, Nebraska, United States
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
Dartmouth Hitchcock Medical Center; Gastroenterology Section
Lebanon, New Hampshire, United States
Portsmouth Regional Hospital; Hem/Onc Clinic
Portsmouth, New Hampshire, United States
Summit Medical Group
Berkeley Heights, New Jersey, United States
Onc & Hematology Specialists
Denville, New Jersey, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Hematology Oncology Associates; Carol G. Simon Ctr
Morristown, New Jersey, United States
Luckow Pavillion, Valley Hosp; Office of Clinical Trials
Paramus, New Jersey, United States
The Mary Imogene Bassett Hospi
Cooperstown, New York, United States
North Shore Hem Onc Associates
East Setauket, New York, United States
Queens Hospital Center
Jamaica, New York, United States
Beth Israel Comprehensive Cancer Center Pharmacy
New York, New York, United States
Herbert Irving Comprehensive Cancer Center; Herbert Irving Pavillion
New York, New York, United States
Hope A Women's Cancer Center
Asheville, North Carolina, United States
Gaston Hematology/Oncology
Gastonia, North Carolina, United States
Cone Health Cancer Center
Greensboro, North Carolina, United States
Southeastern Regional Medical Center
Lumberton, North Carolina, United States
First Health of the Carolinas
Pinehurst, North Carolina, United States
Metro Health Medical Center
Cleveland, Ohio, United States
Mid Ohio Onc Hematology Inc
Columbus, Ohio, United States
Signal Point Clinical; Research Center, LLC
Middletown, Ohio, United States
Flower Memorial Hospital
Sylvania, Ohio, United States
Mercy Clinic Oklahoma Communties, Inc
Oklahoma City, Oklahoma, United States
Cancer Care Assoc-15th St
Tulsa, Oklahoma, United States
Providence Cancer Center
Portland, Oregon, United States
Hematology & Oncology Assoc; North Eastern Pennsylvania
Dunmore, Pennsylvania, United States
Lancaster Cancer Center, Ltd.
Lancaster, Pennsylvania, United States
Temple University Hospital
Philadelphia, Pennsylvania, United States
Allegheny General Hospital; Transplantation Services
Pittsburgh, Pennsylvania, United States
Univ of Pittsburgh Sch of Med; Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
Guthrie Clinic
Sayre, Pennsylvania, United States
Charleston Hematology Oncology
Charleston, South Carolina, United States
Medical Univ of South Carolina
Charleston, South Carolina, United States
South Carolina Oncology Associates - SCRI
Columbia, South Carolina, United States
Chattanooga Oncology and Hematology Associates, PC
Chattanooga, Tennessee, United States
Kingsport Hematology Oncology Associates
Kingsport, Tennessee, United States
Center for Biomedical Research LLC
Knoxville, Tennessee, United States
Boston Baskin Cancer Foundation
Nashville, Tennessee, United States
Sarah Cannon Research Inst.
Nashville, Tennessee, United States
Hendrick Cancer Center
Abilene, Texas, United States
Texas Oncology
Bedford, Texas, United States
St. Joseph Regional Cancer Ct
Bryan, Texas, United States
Texas Oncology-Baylor Sammons Cancer Center
Dallas, Texas, United States
Texas Oncology- El Paso Cancer Treatment Center Gateway
El Paso, Texas, United States
Texas Oncology, P.A. - Fort Worth
Fort Worth, Texas, United States
Texas Oncology - Houston (Gessner)
Houston, Texas, United States
Texas Oncology, P.A. - McAllen; South Texas Cancer Center-McAllen
McAllen, Texas, United States
Texas Oncology - Paris
Paris, Texas, United States
Tyler Hematololgy Oncology, PA
Tyler, Texas, United States
Texas Oncology, PA
Waco, Texas, United States
Texas Oncology, P.A.; Duke Slayton Cancer Center
Webster, Texas, United States
Northern Utah Associates
Ogden, Utah, United States
Huntsman Cancer Institute; Oncology
Salt Lake City, Utah, United States
Lynchburg Hem Onc Clinic Inc
Lynchburg, Virginia, United States
Peninsula Cancer Institute
Newport News, Virginia, United States
Virginia Cancer Institute
Richmond, Virginia, United States
Shenandoah Oncology Associates
Winchester, Virginia, United States
Virginia Mason Medical Center
Seattle, Washington, United States
West Virginia University Hospitals Inc
Morgantown, West Virginia, United States
University of Wisconsin
Madison, Wisconsin, United States
Columbia Saint Mary's; Medical Oncology
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tripathy D, Brufsky A, Cobleigh M, Jahanzeb M, Kaufman PA, Mason G, O'Shaughnessy J, Rugo HS, Swain SM, Yardley DA, Chu L, Li H, Antao V, Hurvitz SA. De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry. Oncologist. 2020 Feb;25(2):e214-e222. doi: 10.1634/theoncologist.2019-0446. Epub 2019 Oct 14.
Cobleigh M, Yardley DA, Brufsky AM, Rugo HS, Swain SM, Kaufman PA, Tripathy D, Hurvitz SA, O'Shaughnessy J, Mason G, Antao V, Li H, Chu L, Jahanzeb M. Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs. Clin Cancer Res. 2020 Mar 1;26(5):1105-1113. doi: 10.1158/1078-0432.CCR-19-2350. Epub 2019 Nov 26.
Hurvitz SA, O'Shaughnessy J, Mason G, Yardley DA, Jahanzeb M, Brufsky A, Rugo HS, Swain SM, Kaufman PA, Tripathy D, Chu L, Li H, Antao V, Cobleigh M. Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs. Clin Cancer Res. 2019 Apr 15;25(8):2433-2441. doi: 10.1158/1078-0432.CCR-18-2366. Epub 2018 Dec 28.
Tripathy D, Rugo HS, Kaufman PA, Swain S, O'Shaughnessy J, Jahanzeb M, Mason G, Beattie M, Yoo B, Lai C, Masaquel A, Hurvitz S. The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. BMC Cancer. 2014 May 2;14:307. doi: 10.1186/1471-2407-14-307.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML28257
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.